Government Priorities & Investment
UK's Biotechnology Priorities
Explore the UK's strategic investments in life sciences, genomics, biotechnology research, and advanced therapies driving innovation across healthcare and the bioeconomy.
Priority Areas
Life Sciences & Biotechnology
Allocation £2Bn+ Lead Organizations Department for Science, Innovation & Technology (DSIT)
Genomics & Bioengineering
Allocation £8Bn+ Lead Organizations UK Research & Innovation (UKRI)
Biotech Startups & Advanced Therapies
Allocation £1Bn+ Lead Organizations Innovate UK
Clinical Innovation & Regulation
Allocation £300M+ Lead Organizations Medicines and Healthcare products Regulatory Agency (MHRA)
Biotechnology Innovation Ecosystem
Allocation £8Bn+ Lead Organizations DSIT UK Research & Innovation (UKRI) Innovate UK
Private / Industry
🧬
AstraZeneca • GSK • Oxford Nanopore
🔬
Wellcome Sanger Institute • BenevolentAI
🤝
BioIndustry Association (BIA)
💰
Oxford Science Enterprises • Syncona • SV Health Investors
Stay Informed on Government Initiatives
Get the latest updates on Technology policies, funding opportunities, and strategic initiatives.